Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.
about
The role of NK cells in HIV-1 protection: autologous, allogeneic or both?Hypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infectionImmune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?Know Thyself: NK-Cell Inhibitory Receptors Prompt Self-Tolerance, Education, and Viral Control.Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 ControllerMechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic ControllersAntiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.A correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllersIncreased frequency and function of KIR2DL1-3⁺ NK cells in primary HIV-1 infection are determined by HLA-C group haplotypes.Immune activation and HIV persistence: implications for curative approaches to HIV infection.Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers.HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles.Natural killer cells in patients with severe chronic fatigue syndrome.Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1.Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification.Isotype Diversification of IgG Antibodies to HIV Gag Proteins as a Therapeutic Vaccination Strategy for HIV Infection.CD8+ and CD4+ cytotoxic T cell escape mutations precede breakthrough SIVmac239 viremia in an elite controllerEvolving role of 2B4/CD244 in T and NK cell responses during virus infection.NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections.Roles of natural killer cells in antiviral immunityNatural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulationBoth HLA-B*57 and plasma HIV RNA levels contribute to the HIV-specific CD8+ T cell response in HIV controllers.Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load.HIV controllers: a genetically determined or inducible phenotype?Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCV.IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.Natural Killer cells in HIV-1 infection and therapy.Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection.KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in Homozygous Individuals
P2860
Q26753146-23A50A45-DF1B-4AEA-9968-E2440DF2BDBCQ27322468-6BACD3D5-3640-4BBC-BD69-448C0500E201Q30362489-FC5DD566-E24D-448D-8540-62EBA9DBE649Q30413217-23BE17FE-FF5F-418B-BD73-626D1EB9F28AQ33809708-26AB3405-C89D-45CF-8D01-92E4D2BED9C8Q33828507-7ABBABE3-079D-40FB-9CDD-589E83945E7DQ33867299-0D78B8A5-0074-4C7A-864B-83BFD8BB7BD0Q33982102-986A4C0A-D954-4C95-9941-002B34DF4E6DQ34339253-31D03C33-CC2B-4F75-9ABA-D90909458151Q34351320-E4243EA3-ACBA-4A50-B24B-240B8CE9408FQ35018065-DFBB986B-4961-45E3-9731-1FE83D6B03AAQ35102172-F1E2E48A-673C-43DD-AB61-2324AA3355F1Q35309120-52DF0E5D-60F8-46A6-9C81-3CB812D23DEBQ35641485-CD4A4583-DF03-4CEE-A8B9-68B9F1A9C546Q35823060-153D8166-472A-44E9-AD1C-4EAF5686D39EQ35826668-75278D38-F6CC-47DF-9DAC-210B73B04E86Q36394661-09BF8B59-E010-4F5A-AD46-008B284733F1Q36457304-787B5F53-6006-4040-BD6C-F498C7330167Q36464528-4DA20EE8-2C3D-4FF3-BCCF-401833AE8E76Q36767761-83C1C1CA-2C22-4D16-AC08-3F50C23C35CDQ37031810-A6F70FE8-EDA2-4370-9304-63703E8AA7C2Q37547677-C5719312-42C9-4B71-BCB9-B9752F8835CDQ38098176-A8056FAC-498F-4331-9ED8-7B274C5CFB49Q38114915-C455A142-5682-49AC-8053-706AB6E29A25Q38234942-93A07A55-E467-4323-9B15-546C2EA48EBDQ40322235-38A94208-47F1-4646-A0E9-7C4156BB1CCBQ41934634-735BB599-4C53-4D92-BC8A-47DB42B05C44Q46722989-5F635EFA-4821-40F5-B59A-E9E97F3D8EAAQ58789985-6F76DB93-849C-484D-A275-7F0B8BBF8AF4
P2860
Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of protective killer in ...... in HIV-1-infected controllers.
@en
Impact of protective killer in ...... in HIV-1-infected controllers.
@nl
type
label
Impact of protective killer in ...... in HIV-1-infected controllers.
@en
Impact of protective killer in ...... in HIV-1-infected controllers.
@nl
prefLabel
Impact of protective killer in ...... in HIV-1-infected controllers.
@en
Impact of protective killer in ...... in HIV-1-infected controllers.
@nl
P2093
P2860
P1433
P1476
Impact of protective killer in ...... in HIV-1-infected controllers.
@en
P2093
Anne Viviani
Costin Tomescu
Fuh-Mei Duh
Kara Harvill
Luis J Montaner
Maureen P Martin
Rebecca Hoh
P2860
P304
P356
10.1097/QAD.0B013E32835861B0
P407
P577
2012-09-01T00:00:00Z